Oncolytics Biotech Inc (ONC.TO)
1.61
+0.02
(+1.26%)
CAD |
TSX |
May 13, 15:17
Oncolytics Biotech Enterprise Value: 85.01M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 10, 2024 | 85.01M |
May 09, 2024 | 92.55M |
May 08, 2024 | 87.27M |
May 07, 2024 | 87.27M |
May 06, 2024 | 86.51M |
May 03, 2024 | 85.76M |
May 02, 2024 | 85.01M |
May 01, 2024 | 81.23M |
April 30, 2024 | 80.48M |
April 29, 2024 | 78.22M |
April 26, 2024 | 75.96M |
April 25, 2024 | 77.46M |
April 24, 2024 | 75.96M |
April 23, 2024 | 72.94M |
April 22, 2024 | 75.20M |
April 19, 2024 | 73.69M |
April 18, 2024 | 72.94M |
April 17, 2024 | 73.69M |
April 16, 2024 | 75.96M |
April 15, 2024 | 75.20M |
April 12, 2024 | 81.23M |
April 11, 2024 | 85.01M |
April 10, 2024 | 83.50M |
April 09, 2024 | 81.99M |
April 08, 2024 | 84.25M |
Date | Value |
---|---|
April 05, 2024 | 82.74M |
April 04, 2024 | 82.74M |
April 03, 2024 | 77.46M |
April 02, 2024 | 72.18M |
April 01, 2024 | 72.94M |
March 28, 2024 | 74.45M |
March 27, 2024 | 69.17M |
March 26, 2024 | 69.17M |
March 25, 2024 | 70.68M |
March 22, 2024 | 69.17M |
March 21, 2024 | 69.92M |
March 20, 2024 | 68.79M |
March 19, 2024 | 69.92M |
March 18, 2024 | 72.18M |
March 15, 2024 | 66.15M |
March 14, 2024 | 69.92M |
March 13, 2024 | 71.43M |
March 12, 2024 | 72.94M |
March 11, 2024 | 72.18M |
March 08, 2024 | 72.18M |
March 07, 2024 | 71.43M |
March 06, 2024 | 68.54M |
March 05, 2024 | 67.05M |
March 04, 2024 | 57.37M |
March 01, 2024 | 77.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.223M
Minimum
Oct 02 2019
257.51M
Maximum
Jul 10 2023
90.87M
Average
84.24M
Median
Enterprise Value Benchmarks
Biocure Technology Inc | 1.49M |
Core One Labs Inc | 9.986M |
Nova Mentis Life Science Corp | 1.447M |
Nanosphere Health Sciences Inc | 0.2414M |
Lobe Sciences Ltd | 1.892M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -3.949M |
Total Expenses (Quarterly) | 8.849M |
EPS Diluted (Quarterly) | -0.05 |
Earnings Yield | -25.50% |